scholarly journals Catalytic inhibitors of DNA topoisomerase II suppress the androgen receptor signaling and prostate cancer progression

Oncotarget ◽  
2015 ◽  
Vol 6 (24) ◽  
pp. 20474-20484 ◽  
Author(s):  
Haolong Li ◽  
Ning Xie ◽  
Martin E. Gleave ◽  
Xuesen Dong
Keyword(s):  
Prostate Cancer ◽  
Androgen Receptor ◽  
Cancer Progression ◽  
Topoisomerase Ii ◽  
Receptor Signaling ◽  
Dna Topoisomerase Ii ◽  
Prostate Cancer Progression ◽  
Dna Topoisomerase ◽  
Androgen Receptor Signaling

scholarly journals BRD9 is a critical regulator of androgen receptor signaling and prostate cancer progression

2020 ◽  
pp. canres.1417.2020
Author(s):  
Aktan Alpsoy ◽  
Sagar M Utturkar ◽  
Benjamin C Carter ◽  
Alisha Dhiman ◽  
Sandra E Torregrosa-Allen ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Androgen Receptor ◽  
Cancer Progression ◽  
Receptor Signaling ◽  
Prostate Cancer Progression ◽  
Androgen Receptor Signaling

Flightless I Homolog Represses Prostate Cancer Progression through Targeting Androgen Receptor Signaling

2015 ◽  
Vol 22 (6) ◽  
pp. 1531-1544 ◽  
Author(s):  
Tao Wang ◽  
Wen Song ◽  
Yuan Chen ◽  
Ruibao Chen ◽  
Zhuo Liu ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Androgen Receptor ◽  
Cancer Progression ◽  
Receptor Signaling ◽  
Prostate Cancer Progression ◽  
Androgen Receptor Signaling

TXNDC9 regulates oxidative stress-induced androgen receptor signaling to promote prostate cancer progression

Oncogene ◽  
2019 ◽  
Vol 39 (2) ◽  
pp. 356-367 ◽  
Author(s):  
Tingting Feng ◽  
Ru Zhao ◽  
Feifei Sun ◽  
Qiqi Lu ◽  
Xueli Wang ◽  
...  
Keyword(s):  
Oxidative Stress ◽  
Prostate Cancer ◽  
Androgen Receptor ◽  
Cancer Progression ◽  
Receptor Signaling ◽  
Prostate Cancer Progression ◽  
Androgen Receptor Signaling
Sign in / Sign up

Export Citation Format

Share Document